• Home Blog Tag Von willebrand disease market

Von Willebrand disease Market

Sep 09, 2025

NeuroNOS’ BA-101 Granted FDA Orphan Drug Status for Glioblastoma; Takeda’s VONVENDI Approval Expanded for Von Willebrand Disease in Adults and Children; Telix Gains FDA Nod on Resubmission Pathway for TLX101-CDx NDA; Saol Therapeutics Receives FDA CRL for SL1009 in Pyruvate Dehydrogenase Complex Deficiency; FDA Grants Breakthrough Therapy Designation to Boehringer’s HERNEXEOS for HER2-Mutant Advanced NSCLC

Oct 25, 2021

von Willebrand disease (VWD) – Misdiagnosis Still Prevalent!

Newsletter/Whitepaper